Research Analysts Set Expectations for Maximus, Inc.’s Q2 2024 Earnings (NYSE:MMS)

Maximus, Inc. (NYSE:MMS) – Research analysts at Zacks Research boosted their Q2 2024 earnings per share (EPS) estimates for shares of Maximus in a note issued to investors on Tuesday, April 23rd. Zacks Research analyst R. Department now anticipates that the health services provider will post earnings of $1.33 per share for the quarter, up from their prior forecast of $1.31. The consensus estimate for Maximus’ current full-year earnings is $5.41 per share. Zacks Research also issued estimates for Maximus’ Q4 2024 earnings at $1.38 EPS, FY2024 earnings at $5.39 EPS, Q3 2025 earnings at $1.35 EPS, Q4 2025 earnings at $1.42 EPS and Q2 2026 earnings at $1.06 EPS.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.06. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The business had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same period in the prior year, the business posted $0.94 earnings per share. The company’s revenue was up 6.2% on a year-over-year basis.

A number of other analysts also recently issued reports on the stock. Raymond James downgraded shares of Maximus from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 3rd. StockNews.com raised Maximus from a “hold” rating to a “buy” rating in a report on Thursday, February 8th.

Maximus Price Performance

Shares of Maximus stock opened at $80.82 on Wednesday. The company has a market capitalization of $4.93 billion, a price-to-earnings ratio of 26.76 and a beta of 0.72. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.71. The stock’s 50-day simple moving average is $82.63 and its 200-day simple moving average is $81.30. Maximus has a 52 week low of $72.39 and a 52 week high of $89.69.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date is Tuesday, May 14th. Maximus’s payout ratio is presently 39.74%.

Insiders Place Their Bets

In other news, CFO David Mutryn sold 8,000 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $83.95, for a total value of $671,600.00. Following the completion of the sale, the chief financial officer now owns 5,124 shares of the company’s stock, valued at approximately $430,159.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.40% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in MMS. Assenagon Asset Management S.A. purchased a new position in shares of Maximus in the first quarter worth about $7,774,000. Louisiana State Employees Retirement System increased its holdings in Maximus by 2.9% in the 1st quarter. Louisiana State Employees Retirement System now owns 17,600 shares of the health services provider’s stock worth $1,477,000 after buying an additional 500 shares during the period. New Century Financial Group LLC purchased a new position in Maximus during the 1st quarter worth approximately $1,069,000. State of Michigan Retirement System lifted its stake in Maximus by 2.7% during the 1st quarter. State of Michigan Retirement System now owns 15,018 shares of the health services provider’s stock valued at $1,260,000 after acquiring an additional 400 shares during the period. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of Maximus by 0.5% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 705,302 shares of the health services provider’s stock valued at $59,175,000 after acquiring an additional 3,680 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.